| 81/278 | US=50 / Câncer Ma WW, Jimeno A, Choti MA. Advances in the treatment of colorectal cancertargeting receptors of disease. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 523-32. ISBN 978-1-60327-086-1. TRATAMENTO DO CANCER COLORECTAL; RECEPTORES DE SEGMENTACAO DE DOENCA; CANCER COLORRETAL; BEVACIZUMAB; CETUXIMAB; PANITUMUMAB; KRAS |
| 82/278 | US=60 / Biol/Mol Yang SY, Sales KM, Winslet MC. Apoptosis in colorectal tumorigenesis and chemotherapy. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 75-109. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; QUIMIOTERAPIA; CARCINOGENESE DO COLO UTERINO; CANCER COLORRETAL; PAPILOMAVIRUS HUMANO (HPV); CARCINOMA COLORRETAL. EPIDEMIOLOGIA; CARCINOMA COLORRETAL. ETIOLOGIA; CARCINOMA COLORRETAL. PATOLOGIA; CARCINOMA COLORRETAL. TRATAMENTO; TUMORIGENESE COLORRETAL; ADENOMA; MUTACAO GENICA |
| 83/278 | US=85 / Biol/Mol Sulkowski S, Wincewicz A, Sulkowska M, Koda M. Transforming growth factor-&*946;1 and regulators of apoptosis: p53, bax, and Bcl-xL in colorectal cancers. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 116-23. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5. TGF-&*946;1; P53; BAX; BCL-XL; PROGRESSAO DO CANCER COLORRETAL; CELULAS INFLAMATORIAS; IMUNOSSUPRESSAO |
| 84/278 | US=23-D / Câncer Auer R, Fong Y. Selection of patients for resection of hepatic colorectal metastases: 18F-fluorodeoxyglucose/positron emission tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 49-60. ISBN 978-1-4020-9803-1. RESSECCAO DE METASTASES HEPATICAS COLORRETAIS; 18F-FLUORO / TOMOGRAFIA POR EMISSAO DE POSITRONS |
| 85/278 | US=23-D / Câncer Machi J. Unresectable livre metastases from colorectal cancer: methodology and prognosis with radiofrequency ablation. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 117-31. ISBN 978-1-4020-9803-1. METODOLOGIA DA ABLACAO POR RADIOFREQUENCIA; PROGNOSTICO USANDO ABLACAO POR RADIOFREQUENCIA; ATUAL PAPEL ABLACAO DE RADIO-FREQUENCIA |
| 86/278 | US=23-D / Câncer Rafaelsen SR. Liver metastases from colorectal cancer: ultrasound imaging. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 355-67. ISBN 978-1-4020-9803-1. |
| 87/278 | US=23-D / Câncer Truant S, Huglo D, Pruvot FR. Colorectal liver metastases: 18F-fluorodeoxyglucose-positron emission tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 387-406. ISBN 978-1-4020-9803-1. METASTASES HEPATICAS COLORRETAIS; 18F-FLUORO-TOMOGRAFIA POR EMISSAO DE POSITRONS |
| 88/278 | US=16-A / Estatística Scott RJ, Lubinski J. Genetic epidemiology studies in hereditary non-polyposis colorectal cancer. In: Verma M. Cancer epidemiology. New York: Humana Press, 2009. p. 89-102. (Methods in Molecular Biology, 472) ISBN 978-1-60327-491-3. CANCER HEREDITARIO NAO-POLIPOSE COLORRETAL; HNPCC; SINDROME DE LYNCH; EPIDEMIOLOGIA GENETICA; GENES MODIFICADORES |
| 89/278 | US=16-A / Estatística Lin OS. Acquired risk factors for colorectal cancer. In: Verma M. Cancer epidemiology. New York: Humana Press, 2009. p. 361-72. (Methods in Molecular Biology, 472) ISBN 978-1-60327-491-3. CANCER COLORRETAL. FATORES DE RISCO; CANCER COLORRETAL; ADENOMA; FATORES DE RISCO; FIBRA; INFLAMATORIO; DOENCA INTESTINAL; VIGILANCIA |
| 90/278 | US=13 / Estatística Potter JD, Hunter D. Colorectal cancer. In: Adami HO, Hunter D, Trichopoulos D. Textbook of cancer epidemiology. 2nd ed. Oxford: University Press, 2008. p. 275-307. (Monographs in Epidemiology and Biostatistics) ISBN 978-0-19-531117-4. |
| 91/278 | US=14 / Câncer Anwar N, Badar F, Yusuf MA. Profile of patients with colorectal cancer at a tertiary care cancer hospital in pakistan. In: Branicki FJ, Adem A, Ghazal-Aswad S, Torab FC. Recent advances in clinical oncology. Boston: Blackwell, 2008. p. 199-203. ISBN 978-1-57331-700-9. |
| 92/278 | Câncer Costa H, Lima FO,Barrezueta LFM, Oshima CTF, Silva Júnior JA, Gomes TS, Artigiani Neto R, Franco M. Correlation between immunoexpression of BCL-2 protein family with apoptosis index, cellular proliferation and survival in colorectal carcinomas. Applied Cancer Research, São Paulo: Tecmedd, v.31, n.3, p. 74-80, 2011. ISSN 1980-5578. Disponível em: http://accamargo.phlnet.com.br/applied/ACR2011;31p.74-80.pdf APOPTOSE; PROLIFERACAO CELULAR; NEOPLASIAS COLORRETAIS; ANALISIS MICROARRAIS; PROTEINA BCL2 |
| 93/278 | Câncer Silva SRM, Matos D, Waitzberg AFL, Artigiani R, Saad SS. Study of APC and &*946;-catenin protein expression in polyps and colorectal adenocarcinoma. Applied Cancer Research, São Paulo: Tecmedd, v.31, n.3, p. 81-6, 2011. ISSN 1980-5578. Disponível em: http://accamargo.phlnet.com.br/applied/ACR2011;31p.81-6.pdf ADENOMATOSE; POLIPOSE FAMILIAL; NEOPLASIAS COLORRETAIS; BETA CADERIN |
| 94/278 | Câncer Santos EMM, Rossi BM, Lourenço MTC. Predictors of quality of life in colorectal cancer patients treated with curative intention. Applied Cancer Research, São Paulo: Tecmedd, v.31, n.3, p. 87-91, 2011. ISSN 1980-5578. Disponível em: http://accamargo.phlnet.com.br/applied/ACR2011;31p.87-91.pdf |
| 95/278 | US=28 / Biol/Mol Grothey A. Antiangiogenesis agents in colorectal cancer. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 371-84. ISBN 978-1-58829-870-6. |
| 96/278 | US=23-C / Câncer Hayat MA. Introduction: colorectal cancer. In: ___. Methods of cancer diagnosis, therapy and prognosis: colorectal cancer. v.4. New York: Springer, 2008. p. 3-9. ISBN 978-1-4020-9544-3. |
| 97/278 | US=23-C / Câncer Shinji S, Naito Z, Ishiwata T, Matsuda Y, Seya T, Tajiri T. Poorly differentiated colorectal adenocarcinoma (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: colorectal cancer. v.4. New York: Springer, 2008. p. 13-23. ISBN 978-1-4020-9544-3. CANCER COLORRETAL; ADENOCARCINOMA COLORRETAL POUCO DIFERENCIADO; HISTOPATOLOGIA; IMUNOHISTOQUIMICA; HIBRIDIZACAO IN SITU |
| 98/278 | US=23-C / Câncer Alnabulsi A, Carpenter B, Telfer C, Murray GI. Colorectal cancer: immunohistochemical diagnosis with heterogeneous nuclear ribonucleoprotein K. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: colorectal cancer. v.4. New York: Springer, 2008. p. 25-42. ISBN 978-1-4020-9544-3. CANCER COLORRETAL; DIAGNOSTICO; IMUNOHISTOQUIMICA; RIBONUCLEOPROTEINA K; BIOMARCADORES |
| 99/278 | US=23-C / Câncer Obradovic V, Artiko V. Metastases and recurrence of colorectal cancer: diagnostic role of immunoscintigraphy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: colorectal cancer. v.4. New York: Springer, 2008. p. 43-63. ISBN 978-1-4020-9544-3. CANCER COLORRETAL; METASTASES; RECORRENCIA; DIAGNOSTICO; IMUNOCINTIGRAFIA |
| 100/278 | US=23-C / Câncer Flamini E, Calistri D, Mercatali L, Rengucci C, Amadori D. Colorectal cancer diagnosis using DNA levels in blood and stool. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: colorectal cancer. v.4. New York: Springer, 2008. p. 65-81. ISBN 978-1-4020-9544-3. CANCER COLORRETAL; DIAGNOSTICO; NIVEIS DE DNA; EXAME DE FEZES; EXAME DE URINA |